We believe industry focus is an important component of our strategy, and a core strength to the management teams and discerning investors  with whom we collaborate.

Whether a disruptive, early-to-late-stage company; niche venture fund; or innovative, lower middle-market business, the primary verticals include:

  • MedTech: Novel Medical Devices (Respiratory, Cardiovascular, and Neurological) and 3D Bioprinting
  • BioTech: Precision Medicine, Infectious Disease Diagnosis/Treatment, Ocular Disease, and Genome Editing
  • NanoTech: Aerospace, Optics, Energy, Diagnostics, and Water
  • Frontier Tech: Blockchain, Applied Artificial Intelligence & Machine Learning, Robotics, IoT/IIoT, AR/VR, and Automation
  • Digital Health: Diagnostics and Therapeutics
  • Sustainability and Impact
  • SaaS

Strategic Advisory Board

adv_boardThe Strategic Advisory Board (SAB) compliments the ongoing activities of  10 || 2 Capital Partners, LLC and select clients. Comprised of  influential senior executives and leading professionals, the SAB provides a rich source of industry contacts, operating experience and strategic insight in the focused industry verticals.